Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Retinal Cell Protection in Ocular Excitotoxicity Diseases. Possible Alternatives Offered by Microparticulate Drug Delivery Systems and Future Prospects.

Villanueva JR, Martín Esteban J, Rodríguez Villanueva LJ.

Pharmaceutics. 2020 Jan 24;12(2). pii: E94. doi: 10.3390/pharmaceutics12020094. Review.

2.

A Reassessment of the Marrubium Vulgare L. Herb's Potential Role in Diabetes Mellitus Type 2: First Results Guide the Investigation toward New Horizons.

Rodríguez Villanueva J, Martín Esteban J, Rodríguez Villanueva L.

Medicines (Basel). 2017 Aug 2;4(3). pii: E57. doi: 10.3390/medicines4030057.

3.

Solving the puzzle: What is behind our forefathers' anti-inflammatory remedies?

Rodriguez Villanueva J, Martín Esteban J, Rodríguez Villanueva L.

J Intercult Ethnopharmacol. 2016 Dec 8;6(1):128-143. doi: 10.5455/jice.20161204021732. eCollection 2017 Jan-Mar. Review.

4.

Experimental and Clinical Pharmacology of Ziziphus jujuba Mills.

Rodríguez Villanueva J, Rodríguez Villanueva L.

Phytother Res. 2017 Mar;31(3):347-365. doi: 10.1002/ptr.5759. Epub 2017 Jan 13. Review.

PMID:
28084039
5.

Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.

Rodríguez Villanueva J, Rodríguez Villanueva L, Guzmán Navarro M.

Int J Pharm. 2017 Jan 10;516(1-2):342-351. doi: 10.1016/j.ijpharm.2016.11.053. Epub 2016 Nov 23. Review.

PMID:
27889587
6.

Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.

Rodríguez Villanueva J, Navarro MG, Rodríguez Villanueva L.

Int J Pharm. 2016 Sep 10;511(1):359-366. doi: 10.1016/j.ijpharm.2016.07.031. Epub 2016 Jul 18. Review.

PMID:
27436708
7.

An Insight into a Blockbuster Phytomedicine; Marrubium vulgare L. Herb. More of a Myth than a Reality?

Rodríguez Villanueva J, Martín Esteban J.

Phytother Res. 2016 Oct;30(10):1551-1558. doi: 10.1002/ptr.5661. Epub 2016 Jun 8. Review.

PMID:
27271209
8.

Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.

Rodríguez Villanueva J, Bravo-Osuna I, Herrero-Vanrell R, Molina Martínez IT, Guzmán Navarro M.

Eur J Pharm Sci. 2016 Sep 20;92:287-97. doi: 10.1016/j.ejps.2016.03.012. Epub 2016 Mar 14.

PMID:
26987610

Supplemental Content

Loading ...
Support Center